Shimao’s Debt-for-Equity Swap Buys Time—But Core Business Still Losing Half of Every Yuan

The numbers look impressive on paper. Shimao secured backing from 98.75% of its creditors for a plan that restructures about $11.04 billion in offshore debt. The mechanism is a classic debt-for-equity swap: it discharged roughly $12.5 billion in offshore principal and interest in exchange for new long-dated notes and convertible bonds. And the math works: 74% of those convertible bonds were converted into new shares, which is a major step in reducing its immediate debt load.

On the surface, this is a clean financial reset. It pushes maturities out, converts a chunk of debt to equity, and gives the company breathing room. The company points to this as a key step toward stability, alongside extended onshore loans and cost cuts. In the cold light of common sense, though, this is a technicality. It's a lifeline for the balance sheet, not a cure for the core business.

The real-world utility of the deal is measured in parking lots, not boardrooms. Despite the debt restructuring, the fundamental problem remains: the company is selling far fewer homes at lower prices, making its core business unprofitable. The evidence is stark. Contracted sales for 2025 fell 30% year-on-year to RMB23.95 billion. That's a 30% drop in the pipeline of future revenue. Even if you look at the slightly different figure cited in the same report for the first eleven months, it's still a story of contraction.

The bottom line is that the debt deal reduces pressure but does nothing to fix the demand problem. It's like getting a new credit card to pay off old bills while your income keeps shrinking. The convertible bond conversions into equity are a positive step, but they also dilute existing shareholders and signal the company had to offer equity to get the deal done. For now, the company has bought time. But the smell test says the core business is still dying.

The Real Business: Sales, Prices, and the Bottom Line

The debt deal is a financial maneuver. The real story is in the numbers from the operating business, and they tell a story of severe distress. The company's earnings have been in a steep decline, falling at an average annual rate of -36.8%. That's far worse than the industry's -7.2% annual decline. In other words, Shimao's core business is deteriorating at more than five times the pace of its peers. This isn't just a slowdown; it's a collapse.

The profitability picture is even starker. The company's net profit margin is deeply negative at -48.61%. For every yuan of sales it generates, it loses nearly half of it. That's not a company making money; it's a company burning cash to operate. This level of loss makes the debt restructuring a race against time. Even if the balance sheet is cleaned up, a business that loses nearly 50 cents on every dollar of sales has no internal engine to fund its own recovery.

The average selling price of RMB12,192 per square meter is a figure that tells us nothing about demand strength or profitability. It's a headline number that can be misleading. The real story is the 30% drop in contracted sales, which fell to RMB23.953 billion for the entire last year. That's a 30% contraction in the pipeline of future revenue. When a company sells far fewer homes at lower prices, and still loses money on each one, the fundamental problem is clear. The product isn't selling, and the business model is broken.

The bottom line is that the debt deal provides a lifeline, but it does nothing to fix the dying core. The company is hemorrhaging cash from operations while trying to restructure its liabilities. For the stock to have a future, the company first needs to prove it can sell homes profitably again. Right now, the smell test says the business is still dead.

What to Watch: The Path from Restructuring to Real Profitability

The debt deal is a technical reset. The real test is whether the company can now sell homes profitably again. Investors need to watch for concrete, observable signs that demand is returning and the business model is healing. The key metric to monitor is a sustained increase in contracted sales volume and price, not just a one-month spike. The company's contracted sales for the entire last year fell 30% year-on-year. To prove the turnaround, we need to see that trend reverse for several consecutive quarters. A single month of improvement could be noise; a multi-quarter recovery would be the first real kick of the tires.

The mechanism to watch is the company's ability to convert its remaining convertible bonds into cash or equity without further dilution. The restructuring plan issued roughly US$4.5 billion of mandatory convertible bonds, with 74% already converted into new shares. The remaining bonds are a ticking clock. If the company can convert them into cash via a new equity raise, it strengthens the balance sheet further. If it cannot, it may need to issue more shares, diluting existing owners further. The market will watch this closely for any new equity issuance announcements.

The ultimate catalyst will be a future earnings report showing a return to positive net income and a narrowing of the massive sales decline. The company's net profit margin is deeply negative at -48.61%. Until that margin turns positive, the business is still burning cash. The next major report is the fiscal year 2025 results, due on March 27, 2026. That report will be a critical checkpoint. If it shows a smaller loss and a less steep sales decline, it would be a positive signal. If the losses widen or the sales drop accelerates, it would confirm the business is still in freefall.

In short, the path from restructuring to real profitability is narrow. It requires watching the sales numbers for a genuine recovery, the bond conversions for balance sheet strength, and the next earnings report for a bottoming out of losses. Until those three signs align, the company remains a distressed operation, not a viable investment.